These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31575567)

  • 1. Benefits and harms of lower blood pressure treatment targets: systematic review and meta-analysis of randomised placebo-controlled trials.
    Brunström M; Carlberg B
    BMJ Open; 2019 Sep; 9(9):e026686. PubMed ID: 31575567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.
    Brunström M; Carlberg B
    JAMA Intern Med; 2018 Jan; 178(1):28-36. PubMed ID: 29131895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
    Ettehad D; Emdin CA; Kiran A; Anderson SG; Callender T; Emberson J; Chalmers J; Rodgers A; Rahimi K
    Lancet; 2016 Mar; 387(10022):957-967. PubMed ID: 26724178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A
    Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure targets for hypertension in people with diabetes mellitus.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2013 Oct; (10):CD008277. PubMed ID: 24170669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis.
    Albasri A; Hattle M; Koshiaris C; Dunnigan A; Paxton B; Fox SE; Smith M; Archer L; Levis B; Payne RA; Riley RD; Roberts N; Snell KIE; Lay-Flurrie S; Usher-Smith J; Stevens R; Hobbs FDR; McManus RJ; Sheppard JP;
    BMJ; 2021 Feb; 372():n189. PubMed ID: 33568342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses.
    Brunström M; Carlberg B
    BMJ; 2016 Feb; 352():i717. PubMed ID: 26920333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal blood pressure targets for patients with hypertension: a systematic review and meta-analysis.
    Sakima A; Satonaka H; Nishida N; Yatsu K; Arima H
    Hypertens Res; 2019 Apr; 42(4):483-495. PubMed ID: 30948822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled Trial.
    Lee TC; Cavalcanti RB; McDonald EG; Pilote L; Brophy JM
    Am J Med; 2018 Oct; 131(10):1228-1233.e1. PubMed ID: 29906425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure-lowering efficacy of loop diuretics for primary hypertension.
    Musini VM; Rezapour P; Wright JM; Bassett K; Jauca CD
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD003825. PubMed ID: 26000442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic Blood Pressure Control Targets to Prevent Major Cardiovascular Events and Death in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
    Yang Q; Zheng R; Wang S; Zhu J; Li M; Wang T; Zhao Z; Xu M; Lu J; Chen Y; Ning G; Wang W; Bi Y; Xu Y
    Hypertension; 2023 Aug; 80(8):1640-1653. PubMed ID: 37254768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and acceptability of different antihypertensive drug classes for cardiovascular disease prevention: protocol for a systematic review and network meta-analysis.
    Jussil H; Chaimani A; Carlberg B; Brunström M
    BMJ Open; 2021 Mar; 11(3):e044302. PubMed ID: 33782022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line combination therapy versus first-line monotherapy for primary hypertension.
    Garjón J; Saiz LC; Azparren A; Elizondo JJ; Gaminde I; Ariz MJ; Erviti J
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010316. PubMed ID: 28084624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 - benefits and adverse events in older and younger patients with hypertension: overview, meta-analyses and meta-regression analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2018 Aug; 36(8):1622-1636. PubMed ID: 29847485
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.